Guillain-Barré Syndrome Post COVID-19 Infection: A Case Report
Megha Hegde1, Saurav Raj1★, Dhananjay Tikadar1, Sanatkumar Bharamu Nyamagoud1★ Corresponding author
- 1Department of Pharmacy Practice, KLE College of Pharmacy (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Vidyanagar, Hubballi, Karnataka, INDIA.
CORRESPONDENCE
Saurav Raj
Department of Pharmacy Practice, KLE College of Pharmacy (A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi), Vidyanagar, Hubballi, Karnataka, INDIA.
Received: 07-10-2023; Revised: 18-10-2023; Accepted: 15-11-2023.
Volume 16, Issue 1 · pp. 130–133 · PUBLISHED · DOI: 10.5530/jyp.2024.16.17
ABSTRACT
COVID-19 primarily impacts the respiratory system, with neurological manifestations often being thrombotic and affecting the nervous system. However, the specific presentation of demyelinating manifestations remains less clearly defined. While recent research has established a connection between COVID-19 and Guillain-Barré syndrome-a complex neurological disorder characterised by acute or chronic degeneration-the extent of this association and the distinctive features of GBS within this context remain uncertain. In this report, we present the case of acute GBS suspected to be induced by a COVID-19 infection. Notably, this patient did not exhibit any preceding respiratory, gastrointestinal, or systemic illnesses. Consequently, this case underlines the critical importance of acknowledging the potential risk of Guillain-Barré Syndrome following a COVID-19 infection, making a significant contribution to raising awareness about this potential association.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Hegde, M., Raj, S., Tikadar, D., & Nyamagoud, S. B. (). Guillain-Barré Syndrome Post COVID-19 Infection: A Case Report. Journal of Young Pharmacists, 16(1), 130–133. https://doi.org/10.5530/jyp.2024.16.17